The pro-metastatic role of TGF-β extends well beyond melanoma and has been extensively described in other cancers, including, but not restricted to, gliomas, breast, ovarian, colon, or prostate adenocarcinomas [44,45,56-58]. This evidence concerns the gene TGFB1 and cancer.